SLC1A2 and Parkinson disease: Similarly, Wu et al. (2019) found that miR‐543 suppresses the expression and function of GLT‐1, a key glutamate transporter essential for glutamate clearance and neuronal protection; inhibition of miR‐543 was shown to restore GLT‐1 function and alleviate dyskinesia in PD models.